LXRX offering history
Every offering-related filing in LEXICON PHARMACEUTICALS, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,000 filings back to Dec 23, 2009.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 6, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 6, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 30, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 6, 2026 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Feb 2, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 2, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 30, 2026 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jan 30, 2026 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jan 29, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Nov 6, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 15, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 2, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 15, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| May 10, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 10, 2024 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Mar 25, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 11, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 29, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 28, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 2, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jun 2, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 1, 2023 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| May 31, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 31, 2023 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Jan 4, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 29, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 29, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 27, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 17, 2022 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 14, 2021 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 6, 2021 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 11, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 30, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Sep 29, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 24, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 18, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 7, 2019 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Sep 15, 2017 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Mar 20, 2017 | S-3ASR → | REGISTERED | Automatic shelf registration — effective immediately (large filers) |
| Dec 23, 2014 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
LXRX offering FAQ
When did LXRX last execute an offering?
Per SEC filings, LEXICON PHARMACEUTICALS, INC.'s most recent priced offering document is a 8-K filed 2026-05-06. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did LXRX last announce or register an offering?
The most recent registration is a S-3 filed 2026-08-06. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.